rs759429379

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_001387283.1(SMARCA4):​c.534C>A​(p.His178Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H178Y) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SMARCA4
NM_001387283.1 missense

Scores

1
8
10

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0200

Publications

0 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31803548).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.534C>A p.His178Gln missense_variant Exon 4 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.534C>A p.His178Gln missense_variant Exon 4 of 35 ENST00000344626.10 NP_003063.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.534C>A p.His178Gln missense_variant Exon 4 of 36 NM_001387283.1 ENSP00000495368.1
SMARCA4ENST00000344626.10 linkc.534C>A p.His178Gln missense_variant Exon 4 of 35 1 NM_003072.5 ENSP00000343896.4
SMARCA4ENST00000643549.1 linkc.534C>A p.His178Gln missense_variant Exon 4 of 35 ENSP00000493975.1
SMARCA4ENST00000541122.6 linkc.534C>A p.His178Gln missense_variant Exon 5 of 35 5 ENSP00000445036.2
SMARCA4ENST00000643296.1 linkc.534C>A p.His178Gln missense_variant Exon 4 of 34 ENSP00000496635.1
SMARCA4ENST00000644737.1 linkc.534C>A p.His178Gln missense_variant Exon 4 of 34 ENSP00000495548.1
SMARCA4ENST00000589677.5 linkc.534C>A p.His178Gln missense_variant Exon 5 of 35 5 ENSP00000464778.1
SMARCA4ENST00000643995.1 linkc.-55C>A upstream_gene_variant ENSP00000496004.1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1457498
Hom.:
0
Cov.:
34
AF XY:
0.00
AC XY:
0
AN XY:
724774
African (AFR)
AF:
0.00
AC:
0
AN:
33438
American (AMR)
AF:
0.00
AC:
0
AN:
43880
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25998
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39570
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85692
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52544
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1110382
Other (OTH)
AF:
0.00
AC:
0
AN:
60232
GnomAD4 genome
Cov.:
32

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.44
BayesDel_addAF
Uncertain
0.097
D
BayesDel_noAF
Benign
-0.10
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.65
D;.;T;.;.;.;.;.;.;.;D;.;.;.;.;.;T;T
Eigen
Benign
-0.69
Eigen_PC
Benign
-0.57
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.93
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D
M_CAP
Pathogenic
0.33
D
MetaRNN
Benign
0.32
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.45
T
MutationAssessor
Benign
-0.29
N;.;.;.;N;N;.;N;N;N;N;N;N;N;N;N;.;.
PhyloP100
-0.020
PrimateAI
Uncertain
0.77
T
PROVEAN
Benign
-2.1
N;.;.;.;.;.;.;.;.;.;N;.;N;.;N;.;N;N
REVEL
Uncertain
0.55
Sift
Benign
0.18
T;.;.;.;.;.;.;.;.;.;T;.;T;.;T;.;T;T
Sift4G
Benign
0.61
T;.;.;.;.;.;.;.;.;.;T;.;T;T;T;T;T;T
Polyphen
0.0090
B;.;D;.;.;.;.;.;.;.;B;.;.;.;.;.;.;D
Vest4
0.33
MutPred
0.52
Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);Loss of catalytic residue at L180 (P = 0.0602);
MVP
0.76
MPC
0.89
ClinPred
0.77
D
GERP RS
-1.8
PromoterAI
0.015
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.54
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs759429379; hg19: chr19-11097043; API